Thiazole and oxazole kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8962665
APP PUB NO 20130035331A1
SERIAL NO

13521676

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is concerned with substituted azole derivatives that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant proteine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. In particular, several of these compounds are potent and selective Flt-3 inhibitors or/and syk inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AB SCIENCEPARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Benjahad, Abdellah Champigny sur Marne, FR 12 69
Chevenier, Emmanuel Les Ulis, FR 6 22
Martin, Jason L'Hay les Roses, FR 111 2551
Moussy, Alain Paris, FR 75 376
Pez, Didier Nievroz, FR 6 22
Picoul, Willy Lyon, FR 7 28
Sandrinelli, Franck Balan, FR 6 22

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 24, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00